Low-density lipoprotein oxidation is increased in kidney transplant recipients

Transplant International : Official Journal of the European Society for Organ Transplantation
M A van den DorpelW Weimar

Abstract

Oxidative modification of low-density lipoproteins (LDL) plays an important role in the pathogenesis of atherosclerosis. In addition, there is evidence that chronic vascular allograft rejection may be mediated by oxidised LDL. Plasma lipoprotein concentrations and parameters of LDL oxidation were determined in 19 kidney transplant recipients and 19 healthy controls. Plasma triglycerides and total cholesterol was significantly higher in patients than in the controls. The mean LDL diameter was smaller in patients than in the controls (23.6 +/- 0.71 nm vs 27.78 +/- 1.16 nm, P < 0.002). Furthermore, the lag time of copper-induced in vitro LDL oxidation was shorter in patients than in the controls (101 +/- 23 min vs 148 +/- 81 min, P = 0.02). The titre and concentration of both IgG and IgM autoantibodies against malondialdehyde-modified LDL (MDA-LDL) were higher in the patients. We conclude that there is in vitro and in vivo evidence of increased LDL oxidation in renal transplant recipients. This might facilitate the progression of atherosclerosis and enhance the process of chronic vascular rejection.

References

Dec 1, 1976·Canadian Journal of Biochemistry·B Rubenstein, G Steiner
Apr 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J FrostegårdJ Nilsson
Dec 1, 1991·The Journal of Clinical Investigation·J L Witztum, D Steinberg
Sep 15, 1991·The American Journal of Cardiology·Y ChancerelleJ F Kergonou
Jan 1, 1991·Kidney International·G Appel
May 1, 1990·Kidney International·W E Braun
Jun 1, 1988·The American Journal of Medicine·B L Kasiske
Jun 1, 1996·Kidney International·W H Dantzler

❮ Previous
Next ❯

Citations

Jun 24, 1998·Transplantation Proceedings·J B CopleyP Van Veldhuisen

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.